Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.
A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
Tree Folio NYC creates a high-resolution “digital twin” of New York City’s urban canopy, simulating how local conditions influence shading that is important to mitigating climate change and heat island effects.
Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.
Board Governance: Navigating Emerging Technologies and More in a Complex World, a new Cornell Tech immersion program, is set to prepare corporate board members for fast-paced evolutions driving the future of commerce.
Weill Cornell Medicine associate professor Gregory F. Sonnenberg has been awarded a five-year, $3.26 million grant from the National Institutes of Health to investigate the underlying mechanisms of inflammatory bowel disease.
A multi-institution team led by a Weill Cornell Medicine scientist has been approved for $30 million in funding from the Patient-Centered Outcomes Research Institute to study heart procedure outcomes in underrepresented groups.
During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
The initiative is designed to improve standards of online privacy, safety and security, and to establish New York City as the epicenter of cybersecurity research.
